Shandong Xinhua Pharmaceutical (00719) has issued an announcement stating that the Board of Directors has resolved to propose Mr. Liu Weimin (Mr. Liu) as a candidate for appointment as an executive director, subject to approval by the Company's shareholders at an extraordinary general meeting to be held on or around November 10, 2026, based on the recommendation put forward by the Board's nomination committee.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.